Literature DB >> 32360096

Psychological Stress and Chronic Urticaria: A Neuro-immuno-cutaneous Crosstalk. A Systematic Review of the Existing Evidence.

Gerasimos N Konstantinou1, George N Konstantinou2.   

Abstract

PURPOSE: It has been observed that certain patients with chronic spontaneous or idiopathic urticaria (CSU/CIU) have a personal history of a significant stressor before urticaria onset, while the prevalence of any psychopathology among these patients is significantly higher than in healthy individuals. Research has confirmed that skin is both an immediate stress perceiver and a target of stress responses. These complex interactions between stress, skin, and the nervous system may contribute to the onset of chronic urticaria. This systematic review investigated the association between CSU/CIU and neuroimmune inflammation with or without evidence of co-existing psychological stress from in vivo and ex vivo studies in human beings.
METHODS: PubMed and Scopus were searched to September 2019 for reports in human beings describing neuroimmune inflammation, stress, and CSU/CIU. A comprehensive search strategy was used that included all the relevant synonyms for the central concept.
FINDINGS: A total of 674 potentially relevant articles were identified. Only 13 satisfied the predefined inclusion criteria and were included in the systematic review. Five of these 13 studies evaluated the correlation between CSU/CIU, stress, and neuro-immune-cutaneous factors, while the remaining 8 focused on the association between CSU/CIU and these factors without examining any evidence of stress. IMPLICATIONS: The complex neuro-immune-cutaneous model that involves numerous neuropeptides and neurokinins, inflammatory mediators and cells, hypothalamic-pituitary-adrenal axis hormones, and the skin may better explain the underlying pathophysiological mechanisms involved in the onset of urticaria. In addition, the elevated psychological stress level that has been closely related to CSU/CIU could be attributed to the imbalance or irregularity of this neuro-immune-cutaneous circuit. It is still unclear and must be further investigated whether any psychological stress results in or triggers CSU/CIU onset on top of a preexisting neuroimmune dysregulation. Nevertheless, new psycho-phenotypic or neuro-endotypic CSU/CIU subsets should be considered as the era of personalized treatment strategies emerges. A better understanding of CSU/CIU pathophysiology and consideration of the patient as a whole is vital for identifying targets for new potential treatment options.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytokines; Inflammation; Mast cells; Neuroimmune; Neurotransmitters; Skin

Mesh:

Year:  2020        PMID: 32360096     DOI: 10.1016/j.clinthera.2020.03.010

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  5 in total

1.  Psychodermatology in the Era of COVID-19.

Authors:  Bárbara Roque Ferreira; Mohammad Jafferany; Laurent Misery
Journal:  J Clin Aesthet Dermatol       Date:  2021-03-01

2.  Impact of coronavirus disease 2019 on the mental health of university students in Sichuan Province, China: An online cross-sectional study.

Authors:  Kai-Han Yang; Lei Wang; Hui Liu; Lin-Xia Li; Xiao-Lian Jiang
Journal:  Int J Ment Health Nurs       Date:  2021-03-11       Impact factor: 5.100

3.  Stress, Inflammation, and Autoimmunity: The 3 Modern Erinyes.

Authors:  Theoharis C Theoharides
Journal:  Clin Ther       Date:  2020-04-18       Impact factor: 3.393

Review 4.  Further Understanding of Neuro-Immune Interactions in Allergy: Implications in Pathophysiology and Role in Disease Progression.

Authors:  Gerasimos N Konstantinou; Christopher Koulias; Konstantinos Petalas; Michael Makris; George N Konstantinou
Journal:  J Asthma Allergy       Date:  2022-09-10

Review 5.  Navigating patients with atopic dermatitis or chronic spontaneous urticaria during the COVID-19 pandemic.

Authors:  Isabelle Haddad; Kathia Kozman; Abdul-Ghani Kibbi
Journal:  Front Allergy       Date:  2022-10-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.